About US
Contact us
-
CFDA Vice Minister Wu Zhen meets Country Director of U.S. FDA China OfficeOn the morning of August 27, 2015, Wu Zhen, Vice Minister of China Food and Drug Administration (CFDA), met with the delegation led by S. Leigh Verbois, Country Director of U.S. FDA China Office. Both2015/9/2
-
Bernie Sanders proposes raft of legislation to combat rising drug pricesSen. Bernie Sanders, a longtime pharma watchdog, says he's rolling out legislation to stall drug price hikes. The presidential candidate's proposals include some previously failed measures--includingM2015/9/2
-
BMS, AbbVie nab 'breakthrough' tag for multiple myeloma-fighting antibodyA new drug for blood cancer from Bristol-Myers Squibb ($BMY) and AbbVie ($ABBV) is on the fast track to FDA approval, winning a priority review to treat multiple myeloma.Report2015/9/2
-
No change in CV risk for ACS patients on Sanofi's LyxumiaLONDON--Back in June, researchers unveiled details of the ELIXA trial, which put Sanofi's Lyxumia in the clear as far as cardiovascular safety risks go. Now, a new analysis of the study shows that in2015/9/1
-
New hurdle for DPP-4 diabetes meds: FDA spotlights risk of 'disabling' joint painAs if last week'sJardiancenews wasn't enough to worry makers of DPP-4 diabetes drugs, theFDAhas now issued a warning that the class of meds might cause "severe and disabling" joint pain. The agency's2015/9/1
-
Judge halts lawsuit blaming Purdue, Endo and others for epidemic of drug abuseIt was attention-grabbing when California sued a handful of drugmakers, accusing them of lying about the safety of their high-powered painkillers and blaming them for an epidemic of prescription drug2015/8/31
-
Patient education 'useless' when it comes to Eliquis adherence: studyLONDON--Good news for partners Bristol-Myers Squibb and Pfizer: In a Phase IV study of their new-age anticoagulant,Eliquis, atrial fibrillation patients posted adherence rates near 90%. And the icing2015/8/31
-
CFDA issues announcement on further standardizing naming of health foodThe revised Food Safety Law of the People's Republic of China will come into effect as of October 1, 2015. In accordance with the requirement of strict supervision to health food, China Food and Drug2015/8/28
-
The FDA has spoken on biosimilar names. But will its hybrid proposal work?After much industry lobbying and public debate, theFDAhas proposed a system for naming biosimilar drugs. It's a sort of hybrid of the generic name on one hand and the unique brand name on the other. A2015/8/28
-
On the heels of big production news, Novo Nordisk snaps up two diabetes drug developersNovo Nordisk ($NVO) has had a big week. After announcing a $2 billion manufacturing investment Wednesday--and launching a late-stage trial of its oral semaglutide drug to boot--the Danish drugmaker no2015/8/28